News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
169,848 Results
Type
Article (6861)
Company Profile (110)
Press Release (162877)
Section
Business (53940)
Career Advice (357)
Deals (9781)
Drug Delivery (30)
Drug Development (32017)
Employer Resources (69)
FDA (2734)
Job Trends (4147)
News (96687)
Policy (6766)
Tag
2024 BioCapital Digital (3)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (4)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Biotech Bay Standard (6)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (1)
2024 Genetown Standard (4)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (258)
Adcomms (2)
Allergies (26)
Alliances (12285)
ALS (29)
Alzheimer's disease (384)
Antibody-drug conjugate (ADC) (53)
Approvals (2761)
Artificial intelligence (69)
Autoimmune disease (6)
Automation (1)
Bankruptcy (64)
Best Places to Work (3219)
BIOSECURE Act (14)
Biosimilars (40)
Biotechnology (72)
Bladder cancer (16)
Brain cancer (13)
Breast cancer (54)
Cancer (614)
Cardiovascular disease (36)
Career advice (307)
Career pathing (21)
CAR-T (54)
Cell therapy (131)
Cervical cancer (4)
Clinical research (27063)
Collaboration (260)
Compensation (244)
Complete response letters (8)
COVID-19 (657)
CRISPR (7)
C-suite (93)
Cystic fibrosis (26)
Data (695)
Decentralized trials (1)
Denatured (12)
Depression (15)
Diabetes (59)
Diagnostics (603)
Digital health (2)
Diversity (6)
Diversity, equity & inclusion (19)
Drug discovery (27)
Drug pricing (22)
Drug shortages (3)
Duchenne muscular dystrophy (17)
Earnings (23113)
Editorial (24)
Employer branding (10)
Employer resources (60)
Events (33863)
Executive appointments (279)
FDA (3058)
Featured Employer (20)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (191)
Gene editing (17)
Generative AI (9)
Gene therapy (64)
GLP-1 (242)
Government (725)
Guidances (15)
Healthcare (2323)
Huntington's disease (9)
IgA nephropathy (7)
Immunology and inflammation (30)
Indications (12)
Infectious disease (686)
Inflammatory bowel disease (46)
Inflation Reduction Act (6)
Influenza (7)
Intellectual property (35)
Interviews (58)
IPO (5774)
IRA (14)
Job creations (1028)
Job search strategy (262)
Kidney cancer (5)
Labor market (25)
Layoffs (128)
Leadership (12)
Legal (910)
Liver cancer (23)
Lung cancer (101)
Lymphoma (42)
Machine learning (2)
Management (23)
Manufacturing (105)
MASH (38)
Medical device (444)
Medtech (445)
Mergers & acquisitions (4233)
Metabolic disorders (214)
Multiple sclerosis (28)
NASH (8)
Neurodegenerative disease (24)
Neuropsychiatric disorders (7)
Neuroscience (544)
NextGen: Class of 2025 (985)
Non-profit (239)
Northern California (1016)
Now hiring (28)
Obesity (113)
Opinion (79)
Ovarian cancer (30)
Pain (23)
Pancreatic cancer (20)
Parkinson's disease (36)
Partnered (3)
Patents (68)
Patient recruitment (39)
Peanut (15)
People (17236)
Pharmaceutical (38)
Pharmacy benefit managers (1)
Phase I (8179)
Phase II (12477)
Phase III (9096)
Pipeline (409)
Podcasts (44)
Policy (54)
Postmarket research (511)
Preclinical (3054)
Press Release (19)
Prostate cancer (21)
Psychedelics (12)
Radiopharmaceuticals (111)
Rare diseases (97)
Real estate (1202)
Recruiting (29)
Regulatory (5703)
Reports (22)
Research institute (281)
Resumes & cover letters (40)
RNA editing (1)
RSV (10)
Schizophrenia (37)
Series A (34)
Series B (22)
Service/supplier (4)
Sickle cell disease (8)
Southern California (793)
Special edition (16)
Spinal muscular atrophy (43)
Sponsored (5)
Startups (959)
State (1)
Stomach cancer (1)
Supply chain (14)
The Weekly (31)
United States (7539)
Vaccines (156)
Venture capitalists (16)
Webinars (7)
Weight loss (56)
Women's health (7)
Worklife (11)
Date
Today (38)
Last 7 days (237)
Last 30 days (929)
Last 365 days (11986)
2025 (2801)
2024 (12556)
2023 (14350)
2022 (16220)
2021 (17848)
2020 (15222)
2019 (10010)
2018 (7153)
2017 (8951)
2016 (7312)
2015 (9308)
2014 (7077)
2013 (5103)
2012 (4934)
2011 (4847)
2010 (4815)
Location
Africa (167)
Alabama (18)
Arizona (18)
Arkansas (2)
Asia (13533)
Australia (1482)
California (2106)
Canada (493)
China (301)
Colorado (77)
Connecticut (89)
Delaware (69)
Europe (24489)
Florida (260)
Georgia (68)
Idaho (3)
Illinois (100)
India (7)
Indiana (77)
Iowa (5)
Japan (56)
Kansas (50)
Kentucky (7)
Maine (2)
Maryland (226)
Massachusetts (1677)
Michigan (35)
Minnesota (74)
Missouri (16)
Nebraska (6)
Nevada (4)
New Hampshire (4)
New Jersey (761)
New Mexico (7)
New York (710)
North Carolina (345)
Northern California (1016)
Ohio (65)
Oklahoma (4)
Oregon (12)
Pennsylvania (386)
Puerto Rico (5)
Rhode Island (7)
South America (212)
Southern California (793)
Tennessee (8)
Texas (209)
Utah (48)
Virginia (37)
Washington D.C. (12)
Washington State (141)
Wisconsin (9)
169,848 Results for "theravance biopharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Theravance Biopharma, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
Theravance Biopharma, Inc. (“Theravance Biopharma” or the “Company”) (NASDAQ: TBPH) today announced financial and operational results for the first quarter of 2024.
May 13, 2024
·
17 min read
Theravance Biopharma to Participate in an Upcoming May 2024 Investor Conference
Theravance Biopharma, Inc. will participate in a Fireside Chat at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ Monday, May 20 at 11:30 AM EDT and will be hosting in-person meetings with the investment community at the conference.
May 9, 2024
·
1 min read
Business
Theravance Biopharma to Report First Quarter 2024 Financial Results on May 13, 2024
Theravance Biopharma, Inc. will report its first quarter 2024 financial results and provide a business update after market close on Monday, May 13, 2024.
April 29, 2024
·
1 min read
Business
Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Theravance Biopharma, Inc. (“Theravance Biopharma” or the “Company”) (NASDAQ: TBPH) today announced financial and operational results for the fourth quarter of 2023 and full-year ended December 31, 2023.
February 26, 2024
·
23 min read
Theravance Biopharma to Participate in an Upcoming March 2024 Investor Conference
Theravance Biopharma, Inc. will participate in the CNS Corporate Panel Discussion at the TD Cowen 44th Annual Health Care Conference in Boston, MA on Tuesday, March 5 at 10:30 am ET.
February 22, 2024
·
1 min read
Career Advice
The Top 12 Companies Hiring in Biopharma Now
Looking for a biopharma job? Check out the
BioSpace
list of 12 top companies hiring life sciences professionals like you.
March 6, 2025
·
1 min read
·
Angela Gabriel
Job Trends
Biopharma Employees’ Confidence in Employers Dips Month-Over-Month in February
Biopharma employees reporting a positive business outlook for their companies dropped month over month but increased year over year in February, according to the Glassdoor Employee Confidence Index. Glassdoor’s findings align with recent
BioSpace
data.
March 27, 2025
·
2 min read
·
Angela Gabriel
Business
Theravance Biopharma, Inc. Announces Appointment of Jeremy Grant to Board of Directors
Theravance Biopharma, Inc. (“Theravance” or the “Company”) (NASDAQ: TBPH) today announced the appointment to its Board of Directors of Jeremy Grant, who serves as a Special Advisor to Irenic Capital Management LP (“Irenic”).
December 21, 2023
·
8 min read
Job Trends
Getting Jobs Outside of Major Biopharma Hubs Proves Tough,
BioSpace
Finds
Over 80% of those living outside of biopharma’s biggest hubs, like San Diego or Boston, have a tough time finding work, according to a
BioSpace
LinkedIn poll. Biopharma professionals in Oregon and Connecticut and a
BioSpace
recruitment manager share their insights on this issue.
February 27, 2025
·
6 min read
·
Angela Gabriel
Job Trends
Settling for Less: Biopharma Professionals Taking Jobs They’re Overqualified For
Nearly half of
BioSpace
poll respondents recently took a biopharma job they were overqualified for, a finding that didn’t surprise a talent acquisition expert, who said it’s become much more likely to happen.
March 20, 2025
·
5 min read
·
Angela Gabriel
1 of 16,985
Next
